Aragen Life Sciences is a trusted R&D and manufacturing partner that transforms ideas into solutions, keeping clients ahead in the race for better health.

Aragen Life Sciences is a global Contract Research, Development, and Manufacturing Organisation (CRDMO) offering comprehensive end-to-end solutions for both small and large molecules. With a workforce exceeding 3,700 scientists, including over 450 PhDs, the company serves a diverse clientele of more than 400 clients, encompassing seven of the top ten large pharmaceutical firms and over 100 biotechnology companies. Aragen’s operations span Asia, North America, and Europe, providing clients with access to global resources and the advantages of a local presence.

Key Products and Services:

• Small Molecules:
  • Discovery Services: Integrated drug discovery, chemistry, biology, and safety assessment.
  • Development and Manufacturing: Drug substance and product development, analytical development, performance chemicals, custom chemical synthesis, and commercial manufacturing.
• Large Molecules (Biologics):
  • Discovery Services: Integrated discovery, molecular biology, antibody discovery, protein sciences, and cell line development.
  • Development and Manufacturing: Process research and development, bioproduction, developability and analytics, and GMP manufacturing.

Aragen is committed to maintaining the highest standards in quality, environmental health and safety, sustainability, and intellectual property protection. The company has been awarded the EcoVadis Platinum Medal, placing it in the top 1% of companies worldwide for sustainability excellence. With a focus on customer-centric agile partnerships and an innovation-driven mindset, Aragen strives to accelerate clients’ pathways to success from concept to commercialisation.